The potential of BMP signaling in the treatment of CRC has been explored, and it has been found that BMP signaling enhances the cytotoxic effects of chemotherapy, suggesting that combining BMP4 administration with current standard chemotherapy could provide clinical benefits for CRC patients (Lombardo et al. 2011). This evidence concerns the gene BMP4 and colorectal carcinoma.